The dopamine transporter gene (SLC6A3) plays a key role in ADHD treatment, as it encodes a protein responsible for dopamine reuptake, the primary target of stimulant medications like MPH and amphetamines [30]. The gene discussed is SLC6A3; the disease is attention deficit-hyperactivity disorder.